Myriad Genetics Q3 2022 Earnings Preview

Oct. 31, 2022 12:14 PM ETMyriad Genetics, Inc. (MYGN)By: SA News Team
  • Myriad Genetics (NASDAQ:MYGN) is scheduled to announce Q3 earnings results on Tuesday, November 1st, before market open.
  • The consensus EPS Estimate is -$0.08 and the consensus Revenue Estimate is $170.37M (+1.8% Y/Y).
  • Over the last 2 years, MYGN has beaten EPS estimates 75% of the time and has beaten revenue estimates 75% of the time.
  • Over the last 3 months, EPS estimates have seen 0 upward revisions and 6 downward. Revenue estimates have seen 1 upward revision and 3 downward.

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.